Lv1
70 积分 2025-08-04 加入
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
2个月前
已完结
Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
2个月前
已完结
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
2个月前
已完结
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
4个月前
已完结
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
5个月前
已完结
Upregulation of Trop-2 quantitatively stimulates human cancer growth
7个月前
已完结
Recent advances in trophoblast cell‐surface antigen 2 targeted therapy for solid tumors
7个月前
已完结
Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
7个月前
已完结
皖公网安备34019202002308
